Wind数据显示，截至记者发稿时，标普500指数上涨0.51%，纳斯达克指数上涨0.53%，续创历史新高；道琼斯指数上涨0.84%。 8月13日，受美联储降息预期提振，美股三大指数集体高开。 美股科技股上涨。特斯拉涨逾2%，亚马逊涨逾1%，苹果、谷歌、微软、英伟达上涨。 | | | 中概股集体大涨，纳斯达克中国金龙指数开盘大涨逾2%。其中，成分股万物新生涨逾10%，逸仙电商涨逾7%，老虎证券涨逾6%，哔哩哔哩涨近6%。 | 小牛电动 | 4.510 | 4.88% | | --- | --- | --- | | NIU.O | | | | 小马智行 | 14.989 | 4.38% | | PONY.O | | | | 爱奇艺 | 1.931 | 4.36% | | IQ.O | | | | 我们之 | 13.960 | 4.33% | | KC.O | | | 万得中概科技龙头指数大涨逾4%，腾讯控股-ADR涨逾6%。网易、阿里巴巴、美团-ADR、百度集团等涨逾3%。消息面上，腾讯控股公布二季度业绩，收 入同比增长15%至1845亿元，显著高于市场预期。 | < W | | 万得中概科技龙头指数(DRAG) ...

Group 1 - Yongji Co., Ltd. announced on August 13 that it is planning to acquire control of Nanjing Tenafly Electronics Technology Co., Ltd. through a combination of issuing shares and cash payment, and will raise matching funds by issuing shares to no more than 35 specific investors [1][5] - The transaction may constitute a major asset restructuring but will not lead to a change in the actual controller of Yongji Co., Ltd. and does not constitute a restructuring listing [1] - Yongji Co., Ltd. has signed a letter of intent for acquisition with the actual controller of Tenafly, LEE MENG KUN, and the final transaction price will be determined based on reports from qualified auditing and asset evaluation institutions [5] Group 2 - Yongji Co., Ltd. specializes in the design, research and development, production, and sales of cigarette labels and other packaging printing products, and has expanded into the social printing market, including cigarette labels, liquor packaging, and pharmaceutical packaging [5][7] - The company has also ventured into the overseas controlled pharmaceutical industry, exploring a second main business to optimize its industrial layout and cultivate new growth curves [7] - In 2024, Yongji Co., Ltd. reported revenue of 905 million yuan, a year-on-year increase of 10.69%, and a net profit attributable to shareholders of 160 million yuan, a year-on-year increase of 59.77% [7] Group 3 - The overseas controlled pharmaceutical business in Australia is focused on treating chronic pain, cancer pain relief, pediatric epilepsy, and assisting in the treatment of mental illnesses [7] - Yongji Co., Ltd. has previously invested in the semiconductor industry, specifically in Shanghai Aiyuan Semiconductor Co., Ltd., but decided to terminate further investment due to changes in external conditions and delays in the commercialization of technology [7] - As of August 13, Yongji Co., Ltd.'s stock price closed at 10.88 yuan per share, an increase of 3.82% [8]

今年二季度，腾讯实现营收1845.04亿元，同比增长15%；非国际财务报告准则公司权益持有人应占盈利为 630.52亿元，同比增长10%。 8月13日，腾讯控股发布2025年半年度及二季度业绩。2025年上半年，腾讯实现营收3645.26亿元，同比增长 14%；非国际财务报告准则公司权益持有人应占盈利为1243.81亿元，同比增长16%。 三大主业稳健增长 二季度，腾讯三大主要业务收入保持增长。 二季度，腾讯增值服务业务收入同比增长16%至913.68亿元，其中游戏业务在长青战略深化实践及AI能力驱 动下，收入同比增长22%，连续3个季度保持20%以上增速。二季度，本土游戏市场凭借《三角洲行动》 《无畏契约》《和平精英》等产品的出色表现，收入同比增长17%至404亿元；国际市场游戏收入同比增长 35%至188亿元；社交网络收入同比增长6%至322亿元，得益于手游虚拟道具销售、视频号直播服务收入及 音乐付费会员收入的增长。 | | 二零二五年 | 二零二四年 | | 二零二五年 | 二零二四年 | | --- | --- | --- | --- | --- | --- | | | 六月三十日 | 六月三十日 | ...

在2025世界机器人大会上，浙江人形机器人创新中心、湖北人形机器人创新中心、国家地方共建具身智 能机器人创新中心等机构集中亮相。 自2023年以来，上述创新中心陆续成立，他们服务于具身智能机器人生态，成为沟通各地机器人研究成 果、产业需求以及推动行业共创的平台。 如在制造业强省浙江省，浙江人形机器人创新中心在服装纺织行业部分工厂启动了机器人落地试点。浙 江人形机器人创新中心首席科学家熊蓉在接受中国证券报记者采访时介绍，上述工厂落地试验的概念验 证已经完成，之后将进入实际应用阶段。 "从我们的角度看，2024年，机器人行业处于技术打磨、体系打磨阶段。现在，到了新的阶段。算法成 熟度已被充分验证，体系化建设已初步完成，这为机器人落地产业打下了良好的基础。"熊蓉说。 熊蓉还表示，未来两到三年，具身智能模型会更成熟。未来，通用人形机器人或通用具身智能模型有望 出现。 熊蓉表示，推动技术从培育到落地的关键，是开发具备实际应用价值的产品。只有当产品是可进行推广 的，上游企业才会真正参与进来，一起打磨产品。这其中也有高校团队参与，进行校企合作。熊蓉认 为，相比"慢悠悠"地打磨技术，这种方式更有目的性，并且可以与下游企业的场 ...

近日，标普全球中国区主席黄直在接受中国证券报记者专访时表示，作为在华耕耘超过30年的全球知名 金融信息服务机构，标普全球的业务已从信用评级、数据服务，到指数编制、可持续发展评估等多个领 域深度融入中国市场。 未来，公司将持续深耕中国市场，通过专业服务衔接全球资本与中国企业的可持续发展需求，参与并见 证更多产业变革与市场开放进程。 可持续发展实践全球领先 黄直作为标普全球代表参加第三届中国国际供应链促进博览会期间，与全球企业CEO共同考察了中国可 持续发展实践。 链博会上看中国： 她表示，中国在可持续发展领域的理念、技术及实践已处于全球领先水平。从实地走访来看，中国绿色 能源基础设施的系统性建设给人留下深刻印象，光伏、风能、水能、氢能等领域不仅规模领先，还形成 了完整产业链。 以氢能产业为例，黄直表示："有氢能产业园以60%的甲醇加40%的水可转化为氢能，用于发电、供 暖。尽管目前成本较高，但技术迭代正在加速，未来有望像天然气一样，通过技术进步解决安全性顾 虑，成为日常能源的重要组成部分。" 黄直认为，作为能源消耗大国，中国的绿色能源转型不仅关乎能源保障，更是推动全球气候治理的重要 力量。"中国的实践为全球提供 ...

Market Overview - On August 13, the Shanghai Composite Index reached a nearly four-year high, with the ChiNext Index surging by 3.62%. AI hardware stocks experienced significant gains, while sectors such as coal, banking, ports, and logistics faced declines [1][3]. ETF Trading Activity - The total trading volume of ETFs on August 13 was 410.52 billion yuan, marking an increase of nearly 125.5 billion yuan, or over 40%, compared to the previous day. Two ETFs surpassed 20 billion yuan in trading volume [2][4]. - The Hong Kong Securities ETF (513090) had a trading volume of 24.64 billion yuan, up by 10.64 billion yuan from August 12. The Short-term Bond ETF (511360) also saw a significant increase, reaching 22.61 billion yuan [5]. Fund Inflows - The Hang Seng Internet ETF (513330) recorded the highest net inflow of 936 million yuan on August 12. Among the top ten ETFs with net inflows in August, four were related to Hong Kong stocks [7][8]. - The total net inflow for the Hong Kong Internet ETF (159792) exceeded 4.2 billion yuan in August, leading all ETFs [7]. Sector Performance - The AI hardware sector showed strong performance, with the ChiNext 50 ETF (159367) rising by 6.89%, the highest among all ETFs. Several AI-related ETFs also saw gains of over 5.5% [2][3]. - The optical module industry is experiencing a "Davis Double Play" scenario, with optimistic capital expenditures from major cloud companies in AI-related businesses, indicating new investment opportunities for tech firms [3]. Investment Strategy - Industry experts suggest a balanced allocation strategy to manage potential volatility and rapid rotations in the market. Focus areas include AI applications and advanced semiconductor processes, as profitability is expected to gradually materialize as business models become clearer [9].

Core Insights - The People's Bank of China reported that as of the end of July, the social financing scale and M2 growth rate remained high, indicating a suitable monetary environment for the real economy and reflecting a moderately loose monetary policy stance [1][2] Summary by Sections Monetary Policy and Economic Support - In the first half of the year, the People's Bank implemented a series of monetary policies that effectively supported the recovery of the real economy, with expectations that the effects of these policies will continue to manifest [1][2] Loan and Financing Data - In the first seven months, RMB loans increased by 12.87 trillion yuan, with the total RMB loan balance reaching 268.51 trillion yuan by the end of July, reflecting a year-on-year growth of 6.9% [2][3] - The social financing scale stock was 431.26 trillion yuan at the end of July, with a year-on-year growth of 9% [2][7] - The cumulative increase in social financing scale for the first seven months was 23.99 trillion yuan, which is 5.12 trillion yuan more than the same period last year [2] Loan Growth Influences - Loan growth is influenced by the macroeconomic background of structural transformation and lighter funding needs, as well as the development of direct financing and diversified financing channels [3][6] - Factors such as local government debt replacement and the reform of small and medium-sized banks have significantly impacted loan growth, with estimates suggesting these factors have contributed over 1 percentage point to the current loan growth rate [3][6] Interest Rates and Financing Costs - Loan interest rates have been at low levels, with new corporate loan rates around 3.2% and new personal housing loan rates around 3.1%, both down approximately 45 and 30 basis points year-on-year, respectively [4][5] - The reduction in financing costs has positively impacted corporate profitability and demand expansion, with many companies now able to invest in new projects due to lower interest rates [5] Financing Structure and Trends - The growth rate of bond financing has outpaced that of credit financing, indicating an ongoing optimization of the financing structure in China [7][8] - By the end of July, M2 stood at 329.94 trillion yuan, with a year-on-year growth of 8.8%, while M1 was 111.06 trillion yuan, growing by 5.6% [7][8] Economic Outlook - The overall economic environment has shown steady improvement, with macroeconomic indicators performing better than expected, supporting the reasonable growth of monetary totals [8] - The continuity and stability of macro policies are expected to support employment, businesses, and market confidence, ensuring a smoother domestic economic cycle [8]

Core Insights - QFII has significantly increased its presence in the A-share market, with 64 companies reporting QFII as a top ten shareholder, holding a total of 3.65 billion shares valued at 6.399 billion yuan as of August 12, 2025 [2][3] Company Summaries - The top holding by QFII is Ninebot Company-WD, with a holding value of 1.169 billion yuan, followed by Oriental Yuhong and Haida Group with holdings of 1.017 billion yuan and 503 million yuan respectively [2][3] - QFII has newly entered the top ten shareholders of 28 companies in the second quarter, with notable entries including Zhongchong Co. and Zhuhai Group, each exceeding 100 million yuan in holding value [3][4] Industry Insights - QFII's holdings in the automotive sector exceed 1.308 billion yuan, while holdings in the building materials and electrical equipment sectors are over 1.118 billion yuan and 1.070 billion yuan respectively [7][8] - The top ten industries by QFII holdings include automotive, building materials, and electrical equipment, indicating a strong focus on these sectors [8] Changes in Holdings - QFII increased its holdings in 18 stocks during the second quarter, with Ninebot Company-WD seeing the largest increase of 9.686 million shares [4][6] - Other significant increases in holdings include Hongfa Technology and Jitai Co., with increases of 5.373 million shares and 4.381 million shares respectively [4][6]

8月6日，福建海西新药创制股份有限公司（简称"海西新药"）再次向港交所递交招股书，华泰国际和招银国际担任其联席保荐人。今年1月3日，海西新药 首次递交招股书。 与多家创新药企业在亏损状态下遵从18A制度谋求在港股上市的情况不同，海西新药拥有获得国家药监局批准的14款仿制药，并凭借仿制药的销售实现盈 利。2024年，海西新药来自VBP（即国家药品集中带量采购）计划的销售金额占总销售金额的九成。 但其主要产品瑞安妥、海慧通的VBP纳入有效期将在2025年12月31日结束。招股书提示，如果相应的产品被剔除出VBP名录或其他政府资助的医保计划， 公司的业务、运营业绩及财务状况可能会受到不利影响。而依靠仿制药"供血"的创新药研发也将遭遇危机。 靠仿制药赚钱 海西新药几乎所有的销售收入均来自销售仿制药。公司表示，未来销售收入也将主要来自仿制药。具体来看，安必力、海慧通、瑞安妥及塞西福四款入选 国家VBP计划的药物，在2024年为海西新药带来的收入分别为1.46亿元、1.87亿元、4794.9万元及4372.9万元。 | | | | 截至12月31日止年度 | | | | | 截至5月31日止五個月 | | | | --- ...

今天，A股继续走强，上证指数、深证成指、创业板指盘中集体创今年以来新高。工业富联（601138）等8只千亿级别市值规模的龙头股创历史新高。 截至收盘，上证指数涨0.48%，深证成指涨1.76%，创业板指涨3.62%。全市场成交额为2.18万亿元，为今年2月27日以来首次突破2万亿元。全市场超2700 只个股上涨，光库科技（300620）、铜冠铜箔（301217）等多只个股"20CM"涨停。 板块方面，有色金属、PEEK材料、CPO、光刻机等板块涨幅居前，煤炭、银行、港口、物流等板块跌幅居前。 具体来看，军工板块领涨，航天科技（000901）近7日斩获5个涨停板，长城军工（601606）股价创历史新高；证券板块全天保持强势，东方财富 （300059）全天成交额突破200亿元，达203.82亿元，居A股第一。此外，工业富联、新易盛（300502）、中际旭创（300308）等多只AI龙头股创历史新 高。 八大千亿龙头股创历史新高 今天，工业富联、紫金矿业（601899）、洛阳钼业（603993）、胜宏科技（300476）、中际旭创、新易盛、深南电路（002916）、寒武纪等8只千亿市值 龙头股，收盘股价（前复权）创 ...